We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more
Ask ADVFN Intelligence (AI)
-- Navenibart (STAR-0215), the Potential Market-Leading Therapy for the Treatment of Hereditary Angioedema, on Track for Expected Phase 3 Initiation in Q1 2025 -- -- Final 3- and 6-Month Results...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 210,000...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.115 | -18.3434518647 | 11.53 | 11.75 | 8.61 | 345866 | 9.59508833 | CS |
| 4 | -1.925 | -16.975308642 | 11.34 | 12.515 | 8.61 | 246170 | 10.88948361 | CS |
| 12 | -2.675 | -22.1257237386 | 12.09 | 12.92 | 8.61 | 324314 | 11.38866038 | CS |
| 26 | -0.095 | -0.998948475289 | 9.51 | 12.92 | 8.585 | 364411 | 10.5998296 | CS |
| 52 | 4.865 | 106.923076923 | 4.55 | 16.9 | 4.41 | 608227 | 11.11999847 | CS |
| 156 | 2.615 | 38.4558823529 | 6.8 | 16.9 | 2.36 | 305043 | 10.48293844 | CS |
| 260 | 0.885 | 10.3751465416 | 8.53 | 16.9 | 2.36 | 289742 | 10.44749525 | CS |
Monksdream
2 months ago
Monksdream
5 months ago
Monksdream
7 months ago
GreenStockEVs
1 year ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
